Petco Announces Director Change and Compensatory Arrangements

Ticker: WOOF · Form: 8-K · Filed: 2024-07-17T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, director-change, executive-compensation

Related Tickers: WOOF

TL;DR

Petco board shakeup: Nazzaro out as director, new director in, plus executive pay details.

AI Summary

Petco Health & Wellness Company, Inc. filed an 8-K on July 17, 2024, reporting the departure of Director Michael J. Nazzaro and the election of new Director Michael J. Nazzaro. The filing also disclosed compensatory arrangements for certain officers and included financial statements and exhibits.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance changes and disclosures, with no immediate indication of significant financial distress or operational disruption.

Key Players & Entities

FAQ

Who is the new director elected to the board of Petco Health & Wellness Company, Inc.?

Michael J. Nazzaro was elected as a new director.

When was this 8-K filing submitted?

The filing was submitted on July 17, 2024.

What other items are reported in this 8-K filing besides director changes?

The filing also reports on compensatory arrangements of certain officers and includes financial statements and exhibits.

What was the previous role of Michael J. Nazzaro in relation to the board?

Michael J. Nazzaro previously served as a Director and has now been re-elected as a Director.

In which state is Petco Health & Wellness Company, Inc. incorporated?

The company is incorporated in Delaware.

From the Filing

0001193125-24-180399.txt : 20240717 0001193125-24-180399.hdr.sgml : 20240717 20240717163001 ACCESSION NUMBER: 0001193125-24-180399 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240717 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Petco Health & Wellness Company, Inc. CENTRAL INDEX KEY: 0001826470 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-RETAIL STORES, NEC [5990] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 811005932 STATE OF INCORPORATION: DE FISCAL YEAR END: 0225 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39878 FILM NUMBER: 241122562 BUSINESS ADDRESS: STREET 1: 10850 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 1-858-453-7845 MAIL ADDRESS: STREET 1: 10850 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: PET Acquisition LLC DATE OF NAME CHANGE: 20200929 FORMER COMPANY: FORMER CONFORMED NAME: Petco Acquisition LLC DATE OF NAME CHANGE: 20200929 8-K 1 d845993d8k.htm FORM 8-K Form 8-K Petco Health & Wellness Company, Inc. false 0001826470 0001826470 2024-07-17 2024-07-17     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2024     Petco Health and Wellness Company, Inc. (Exact name of Registrant as Specified in Its Charter)       Delaware   001-39878   84-1005932 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.) 10850 Via Frontera San Diego , California 92127 (Address of Principal Executive Offices) (858) 453-7845 (Registrant’s Telephone Number, including Area Code) (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Class A common stock, par value $0.001 per share   WOOF   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Chief Executive Officer (“CEO”) On July 17, 2024, the Board of Director

View on Read The Filing